The U.S. Food and Drug Administration has approved Verastem's combination therapy for patients with a type of ovarian cancer ...

Capricor Therapeutics saw its shares fall 13% by the end of trading Monday as its investigational cell therapy deramiocel for ...

Good morning and welcome to Kelly Services First Quarter 2025 Earnings Conference Call. All parties will be on listen-only until the question-and-answer portion of the presentation. Today's call is ...

Spencer resident enjoys football and basketball but holds a special place for baseball, in which he stars at plate and on ...

The process was developed last November in response to a South Carolina Department of Education memo seeking to provide ...

President Donald Trump’s administration released a lengthy review of transgender health care on Thursday that advocates for a ...

Interest in your news is subject to overlap across these channels. Information is used at the discretion of the Department of Occupational Therapy and will be published at a time and with a frequency ...

There aren’t many cures for people who hear phantom ringing or buzzing noises — but there are ways to manage the condition.

Children's Wisconsin says it accidentally ‘discarded’ the frozen portion of a young woman's donated brain. Ashtyn Fellenz, ...

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...

HOLLISTON, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the "Company”) today announced financial results for the first quarter ended March 31, 2025.